News

When you buy something by clicking links within this article, we may earn a small commission, but it never affects the ...
Novavax is undervalued, presenting an attractive risk-reward profile for long-term investors. Click here to find out why NVAX ...
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of ...
Improvements in our understanding of the human genome, technological tools like artificial intelligence, and global ...
The FDA has chosen Dr Vinay Prasad, a professor at UCSF, to lead its Center for Biologics Evaluation and Research.
Meanwhile, health secretary Robert F. Kennedy Jr. and his lieutenants have sent multiple signals in recent weeks that they ...
Leaders at the FDA, HHS and elsewhere are putting guardrails around COVID-19 boosters, which could mean delayed shots or ...
The cells targeted the cancer and eradicated it. Thirteen years later, Whitehead is still cancer-free. Since then, however, ...
Seventy-five years of preparation for an outbreak like that of COVID-19—and yet, the Centers for Disease Control and ...
Donald Trump has recently made a range of nominations/appointments in the US health sector. They will influence conventional and so-called alternative medicine (SCAM) in the US and beyond. It ...
PHILADELPHIA -- The next big world war won't be a nuclear war, or a chemical war -- it will be a war with bioweapons, said ...
Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...